dr. HM (Hedwig) Blommestein

Erasmus School of Health Policy & Management

Associate professor | Health Technology Assessment (HTA)

Email: blommestein@eshpm.eur.nl

Pure profile

Work

Gabe S. Sonke, Annemiek van Ommen-Nijhof, , Noor Wortelboer, Vincent van der Noort, Astrid C.P. Swinkels, Hedwig M. Blommestein, Cristina Guerrero Paez, Linda Mol, Aart Beeker, Karin Beelen, Lisanne C. Hamming, Joan B. Heijns, Aafke H. Honkoop, Paul C. de Jong, Quirine C. van Rossum-Schornagel, Christa van Schaik-van de Mheen, Jolien Tol, Cathrien S. Tromp-van Driel, Suzan Vrijaldenhoven, A. Elise van Leeuwen-Stok, Inge R. Konings & Agnes Jager (2024) - Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer - Nature - doi: 10.1038/s41586-024-08035-2 - [link]
M. R. Seefat, C. A.M. Stege, B. I. Lissenberg-Witte, M. D. Levin, G. J. Timmers, M. Hoogendoorn, P. F. Ypma, S. K. Klein, G. A. Velders, M. Westerman, L. Strobbe, N. Durdu-Rayman, M. A. Davidis-van Schoonhoven, R. J.W. van Kampen, A. C. Dijk, A. Koster, M. H. Silbermann, E. van der Spek, A. Beeker, Z. Erjavec, N. C.H.P. de Graauw, M. B.L. Leys, P. Sonneveld, N. W.C.J. van de Donk, K. Nasserinejad, H. M. Blommestein, D. G.J. Cucchi & S. Zweegman (2024) - Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial - European Journal of Cancer, 207 - doi: 10.1016/j.ejca.2024.114153 - [link]
Christine Bennink, Mirian Brink, Saskia F.A. Duijts, Hans Scheurer, Pieter Sonneveld & Hedwig M. Blommestein (2024) - Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands - Clinical Lymphoma, Myeloma and Leukemia, 24 (9), 604-610 - doi: 10.1016/j.clml.2024.04.004 - [link]
M. R. Seefat, D. G.J. Cucchi, K. Groen, M. L. Donker, K. G. van der Hem, M. Westerman, A. M. Gerrits, A. Beeker, N. W.C.J. van de Donk, H. M. Blommestein & S. Zweegman (2024) - Treatment sequences and drug costs from diagnosis to death in multiple myeloma - European Journal of Haematology, 112 (3), 360-366 - doi: 10.1111/ejh.14119 - [link]
H. R. Mortensen, P. Populaire, L. Hoffmann, D. S. Moeller, A. Appelt, P. Nafteux, C. T. Muijs, C. Grau, M. A. Hawkins, E. G.C. Troost, G. Defraene, R. Canters, C. S. Clarke, D. C. Weber, E. W. Korevaar, K. Haustermans, M. Nordsmark, Val Gebski, M. P. Achiam, Sheraz R. Markar, Ganesh Radhakrishna, Maaike Berbee, Daniele Scartoni, Ester Orlandi, Jerome Doyen, Vincent Gregoire, Gilles Crehange, Johannes Langendijk, Paula Lorgelly, Hedwig M. Blommestein, Camilla S. Byskov, Mai L. Ehmsen, Maria Fuglsang Jensen, Gloria Vilches Freixas, Rebecca Bütoft & (2024) - Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer - Radiotherapy and Oncology, 190 - doi: 10.1016/j.radonc.2023.109980 - [link]
Marianne Luyendijk, Agnes Jager, Sanne M. Buijs, Sabine Siesling, Carin A.Uyl de Groot & Hedwig M. Blommestein (2023) - Cost-Effectiveness Analysis of MammaPrint<sup>®</sup> to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer - PharmacoEconomics, 41 (8), 981-997 - doi: 10.1007/s40273-023-01277-4 - [link]
Brenda Leeneman, Hedwig M. Blommestein, Annemieke van Dongen-Leunis, Mattia Algeri, Willem E. Fibbe, Liesbeth Oosten, Carin A. Uyl-de Groot & Frederick W. Thielen (2023) - Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease - European Journal of Haematology, 111 (2), 240-246 - doi: 10.1111/ejh.13987 - [link]
Christine Bennink, Hans Westgeest, Daan Schoonen, Femke Boersen, Pieter Sonneveld, Jan Hazelzet, Hedwig Blommestein & Marjolein Van Der Klift (2023) - High Hospital-related Costs at the End-of-life in Patients With Multiple Myeloma: A Single-center Study - HemaSphere, 7 (6) - doi: 10.1097/HS9.0000000000000913 - [link]
Marianne Luyendijk, Otto Visser, Hedwig M. Blommestein, Ignace H.J.T. de Hingh, Frank J.P. Hoebers, Agnes Jager, Gabe S. Sonke, Elisabeth G.E. de Vries, Carin A. Uyl-de Groot & Sabine Siesling (2023) - Changes in survival in de novo metastatic cancer in an era of new medicines - Journal of the National Cancer Institute, 115 (6), 628-635 - doi: 10.1093/jnci/djad020 - [link]
Lj Bakker, Fw Thielen, Wk Redekop, CA Uyl de Groot & Hm Blommestein (2023) - Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma - BMC Medical Research Methodology, 23 (1) - doi: 10.1186/s12874-023-01952-2 - [link]